天際股份(002759.SZ):預計半年度虧損5000萬元–6500萬元
格隆匯7月14日丨天際股份(002759.SZ)公佈,預計半年度虧損5,000萬元–虧損6,500萬元,扣非虧損5,000萬元–虧損6,500萬元。報告期內公司虧損,主要原因是公司主要產品六氟磷酸鋰由於行業產能仍然處於階段性過剩階段,市場競爭導致銷售價格處於低位,不能覆蓋完全成本。報告期內公司另外兩項主營業務,子公司新特化工的磷化工系列產品略有盈利,公司小家電板塊業務基本持平。報告期內公司較上年同期實現大幅減虧,主要原因是公司六氟磷酸鋰業務板塊在降本控費方面加大力度,取得了一定成效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.